1666 Stock Overview
Tong Ren Tang Technologies Co. Ltd. produziert und vertreibt Produkte der chinesischen Medizin in Festlandchina und Hongkong.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 1666 from our risk checks.
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$4.99 |
52 Week High | HK$8.97 |
52 Week Low | HK$4.82 |
Beta | 1.04 |
1 Month Change | -2.92% |
3 Month Change | -21.91% |
1 Year Change | -29.42% |
3 Year Change | -12.91% |
5 Year Change | -54.22% |
Change since IPO | 596.28% |
Recent News & Updates
Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly
Mar 28Subdued Growth No Barrier To Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Price
Feb 01Recent updates
Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly
Mar 28Subdued Growth No Barrier To Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Price
Feb 01With EPS Growth And More, Tong Ren Tang Technologies (HKG:1666) Makes An Interesting Case
Dec 20Tong Ren Tang Technologies (HKG:1666) Could Easily Take On More Debt
Oct 12Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 38% Discount?
Sep 19Do Tong Ren Tang Technologies' (HKG:1666) Earnings Warrant Your Attention?
Apr 13Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?
Dec 01Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly
Aug 30Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 43% Discount?
Jul 11Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly
Apr 21We Think Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt With Ease
Dec 22Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly
Sep 06Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?
Apr 25Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Intrinsic Value Is Potentially 22% Below Its Share Price
Mar 20Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) A Great Dividend Stock?
Feb 21Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Feb 03If You Had Bought Tong Ren Tang Technologies' (HKG:1666) Shares Three Years Ago You Would Be Down 61%
Jan 16What Can We Learn About Tong Ren Tang Technologies' (HKG:1666) CEO Compensation?
Dec 28Does This Valuation Of Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Imply Investors Are Overpaying?
Dec 15What Kind Of Shareholders Hold The Majority In Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Shares?
Dec 02Shareholder Returns
1666 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | 2.5% | -1.3% | 0.9% |
1Y | -29.4% | -15.2% | -13.2% |
Rendite im Vergleich zur Industrie: 1666 unter dem Niveau der Branche Hong Kong Pharmaceuticals , die im vergangenen Jahr eine Rendite von -18.2% erzielte.
Rendite vs. Markt: 1666 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von -15.8 erzielte.
Price Volatility
1666 volatility | |
---|---|
1666 Average Weekly Movement | 5.1% |
Pharmaceuticals Industry Average Movement | 6.2% |
Market Average Movement | 7.4% |
10% most volatile stocks in HK Market | 14.5% |
10% least volatile stocks in HK Market | 3.7% |
Stabiler Aktienkurs: 1666Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: 1666Die wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1669 | 4,030 | Jia Fu Chen | https://www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd. produziert und vertreibt Produkte der chinesischen Medizin in Festlandchina und Hongkong. Das Unternehmen kultiviert, kauft und verkauft auch chinesische medizinische Rohstoffe, produziert und verkauft Salben, Teegetränke und Fußpflegeprodukte, verkauft medizinische Produkte und bietet medizinische Forschung und Entwicklung, Werbung und chinesische medizinische Beratung und Behandlung an.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
1666 fundamental statistics | |
---|---|
Market cap | HK$6.39b |
Earnings (TTM) | HK$638.72m |
Revenue (TTM) | HK$7.33b |
10.0x
P/E Ratio0.9x
P/S RatioIs 1666 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1666 income statement (TTM) | |
---|---|
Revenue | CN¥6.77b |
Cost of Revenue | CN¥3.93b |
Gross Profit | CN¥2.85b |
Other Expenses | CN¥2.26b |
Earnings | CN¥590.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.46 |
Gross Margin | 42.04% |
Net Profit Margin | 8.71% |
Debt/Equity Ratio | 15.1% |
How did 1666 perform over the long term?
See historical performance and comparison